The store will not work correctly when cookies are disabled.
2-Selenoxo-5-(3-thiophen-2-yl-allylidene)-dihydropyrimidine-4,6-dione
ID: ALA4171596
PubChem CID: 145949635
Max Phase: Preclinical
Molecular Formula: C11H8N2O2SSe
Molecular Weight: 311.22
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NC(=[Se])NC(=O)C1=C/C=C/c1cccs1
Standard InChI: InChI=1S/C11H8N2O2SSe/c14-9-8(10(15)13-11(17)12-9)5-1-3-7-4-2-6-16-7/h1-6H,(H2,12,13,14,15,17)/b3-1+
Standard InChI Key: MWPDFCXHHHEYIB-HNQUOIGGSA-N
Molfile:
RDKit 2D
17 18 0 0 0 0 0 0 0 0999 V2000
10.2002 -12.3164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4924 -12.7239 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7805 -12.3164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7805 -11.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4924 -11.0898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2002 -11.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0728 -12.7239 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4924 -10.2706 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0728 -11.0898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3650 -11.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6531 -11.0898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9453 -11.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8602 -12.3100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0584 -12.4830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6509 -11.7711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1985 -11.1659 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.9080 -12.7239 0.0000 Se 0 0 0 0 0 2 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
3 7 2 0
5 8 2 0
9 10 1 0
10 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
12 16 1 0
11 12 1 0
4 9 2 0
1 17 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 311.22 | Molecular Weight (Monoisotopic): 311.9472 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK.. (2018) Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells., 143 [PMID:29133035] [10.1016/j.ejmech.2017.11.006] |